img

Global Drugs Based on CAR T-cell Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Drugs Based on CAR T-cell Market Insights, Forecast to 2034

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer
Market Analysis and InsightsGlobal Drugs Based on CAR T-cell Market
Global Drugs Based on CAR T-cell market is expected to reach to US$ 4087 million in 2024, with a positive growth of %, compared with US$ 2805.8 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Drugs Based on CAR T-cell industry is evaluated to reach US$ 19640 million in 2029. The CAGR will be 29.9% during 2024 to 2029.
The CAR T-cell therapy drug gel market is driven by the revolutionary approach of CAR T-cell therapy in cancer treatment and the demand for targeted and personalized therapies. CAR T-cell therapy involves genetically modifying a patient's own T cells to target and destroy cancer cells. The rise in cancer prevalence and the need for innovative treatments contribute to market growth as healthcare providers seek effective and tailored solutions for patients with difficult-to-treat cancers. Moreover, advancements in gel-based drug delivery systems have improved the precision and safety of CAR T-cell therapy administration. However, the market also faces challenges, including complex manufacturing processes and potential side effects associated with immune response. Additionally, addressing the high cost of CAR T-cell therapies and ensuring scalability and accessibility for broader patient populations can pose obstacles for manufacturers and healthcare systems. To succeed, companies must focus on advancing research and development, collaborating with oncologists to optimize therapy protocols, and addressing the challenges to meet the increasing demand for breakthrough cancer treatments.
Report Covers
This report presents an overview of global Drugs Based on CAR T-cell market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Drugs Based on CAR T-cell market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
Segment by Type
CD19-targeted
BCMA-targeted

Segment by Application


Lymphoma
Multiple Myeloma
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Drugs Based on CAR T-cell introduction, etc. Drugs Based on CAR T-cell Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Drugs Based on CAR T-cell
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs Based on CAR T-cell Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 CD19-targeted
1.2.3 BCMA-targeted
1.3 Market by Application
1.3.1 Global Drugs Based on CAR T-cell Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Lymphoma
1.3.3 Multiple Myeloma
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs Based on CAR T-cell Market Perspective (2018-2029)
2.2 Global Drugs Based on CAR T-cell Growth Trends by Region
2.2.1 Drugs Based on CAR T-cell Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Drugs Based on CAR T-cell Historic Market Size by Region (2018-2024)
2.2.3 Drugs Based on CAR T-cell Forecasted Market Size by Region (2024-2029)
2.3 Drugs Based on CAR T-cell Market Dynamics
2.3.1 Drugs Based on CAR T-cell Industry Trends
2.3.2 Drugs Based on CAR T-cell Market Drivers
2.3.3 Drugs Based on CAR T-cell Market Challenges
2.3.4 Drugs Based on CAR T-cell Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Drugs Based on CAR T-cell by Players
3.1.1 Global Drugs Based on CAR T-cell Revenue by Players (2018-2024)
3.1.2 Global Drugs Based on CAR T-cell Revenue Market Share by Players (2018-2024)
3.2 Global Drugs Based on CAR T-cell Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Drugs Based on CAR T-cell, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Drugs Based on CAR T-cell Market Concentration Ratio
3.4.1 Global Drugs Based on CAR T-cell Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs Based on CAR T-cell Revenue in 2022
3.5 Global Key Players of Drugs Based on CAR T-cell Head office and Area Served
3.6 Global Key Players of Drugs Based on CAR T-cell, Product and Application
3.7 Global Key Players of Drugs Based on CAR T-cell, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs Based on CAR T-cell Breakdown Data by Type
4.1 Global Drugs Based on CAR T-cell Historic Market Size by Type (2018-2024)
4.2 Global Drugs Based on CAR T-cell Forecasted Market Size by Type (2024-2029)
5 Drugs Based on CAR T-cell Breakdown Data by Application
5.1 Global Drugs Based on CAR T-cell Historic Market Size by Application (2018-2024)
5.2 Global Drugs Based on CAR T-cell Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Drugs Based on CAR T-cell Market Size (2018-2029)
6.2 North America Drugs Based on CAR T-cell Market Size by Type
6.2.1 North America Drugs Based on CAR T-cell Market Size by Type (2018-2024)
6.2.2 North America Drugs Based on CAR T-cell Market Size by Type (2024-2029)
6.2.3 North America Drugs Based on CAR T-cell Market Share by Type (2018-2029)
6.3 North America Drugs Based on CAR T-cell Market Size by Application
6.3.1 North America Drugs Based on CAR T-cell Market Size by Application (2018-2024)
6.3.2 North America Drugs Based on CAR T-cell Market Size by Application (2024-2029)
6.3.3 North America Drugs Based on CAR T-cell Market Share by Application (2018-2029)
6.4 North America Drugs Based on CAR T-cell Market Size by Country
6.4.1 North America Drugs Based on CAR T-cell Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Drugs Based on CAR T-cell Market Size by Country (2018-2024)
6.4.3 North America Drugs Based on CAR T-cell Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Drugs Based on CAR T-cell Market Size (2018-2029)
7.2 Europe Drugs Based on CAR T-cell Market Size by Type
7.2.1 Europe Drugs Based on CAR T-cell Market Size by Type (2018-2024)
7.2.2 Europe Drugs Based on CAR T-cell Market Size by Type (2024-2029)
7.2.3 Europe Drugs Based on CAR T-cell Market Share by Type (2018-2029)
7.3 Europe Drugs Based on CAR T-cell Market Size by Application
7.3.1 Europe Drugs Based on CAR T-cell Market Size by Application (2018-2024)
7.3.2 Europe Drugs Based on CAR T-cell Market Size by Application (2024-2029)
7.3.3 Europe Drugs Based on CAR T-cell Market Share by Application (2018-2029)
7.4 Europe Drugs Based on CAR T-cell Market Size by Country
7.4.1 Europe Drugs Based on CAR T-cell Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Drugs Based on CAR T-cell Market Size by Country (2018-2024)
7.4.3 Europe Drugs Based on CAR T-cell Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Drugs Based on CAR T-cell Market Size (2018-2029)
8.2 China Drugs Based on CAR T-cell Market Size by Type
8.2.1 China Drugs Based on CAR T-cell Market Size by Type (2018-2024)
8.2.2 China Drugs Based on CAR T-cell Market Size by Type (2024-2029)
8.2.3 China Drugs Based on CAR T-cell Market Share by Type (2018-2029)
8.3 China Drugs Based on CAR T-cell Market Size by Application
8.3.1 China Drugs Based on CAR T-cell Market Size by Application (2018-2024)
8.3.2 China Drugs Based on CAR T-cell Market Size by Application (2024-2029)
8.3.3 China Drugs Based on CAR T-cell Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Drugs Based on CAR T-cell Market Size (2018-2029)
9.2 Asia Drugs Based on CAR T-cell Market Size by Type
9.2.1 Asia Drugs Based on CAR T-cell Market Size by Type (2018-2024)
9.2.2 Asia Drugs Based on CAR T-cell Market Size by Type (2024-2029)
9.2.3 Asia Drugs Based on CAR T-cell Market Share by Type (2018-2029)
9.3 Asia Drugs Based on CAR T-cell Market Size by Application
9.3.1 Asia Drugs Based on CAR T-cell Market Size by Application (2018-2024)
9.3.2 Asia Drugs Based on CAR T-cell Market Size by Application (2024-2029)
9.3.3 Asia Drugs Based on CAR T-cell Market Share by Application (2018-2029)
9.4 Asia Drugs Based on CAR T-cell Market Size by Region
9.4.1 Asia Drugs Based on CAR T-cell Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Drugs Based on CAR T-cell Market Size by Region (2018-2024)
9.4.3 Asia Drugs Based on CAR T-cell Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Drugs Based on CAR T-cell Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Drugs Based on CAR T-cell Market Size by Type
10.2.1 Middle East, Africa, and Latin America Drugs Based on CAR T-cell Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Drugs Based on CAR T-cell Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Drugs Based on CAR T-cell Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Drugs Based on CAR T-cell Market Size by Application
10.3.1 Middle East, Africa, and Latin America Drugs Based on CAR T-cell Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Drugs Based on CAR T-cell Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Drugs Based on CAR T-cell Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Drugs Based on CAR T-cell Market Size by Country
10.4.1 Middle East, Africa, and Latin America Drugs Based on CAR T-cell Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Drugs Based on CAR T-cell Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Drugs Based on CAR T-cell Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Drugs Based on CAR T-cell Introduction
11.1.4 Novartis Revenue in Drugs Based on CAR T-cell Business (2018-2024)
11.1.5 Novartis Recent Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Drugs Based on CAR T-cell Introduction
11.2.4 Gilead Sciences Revenue in Drugs Based on CAR T-cell Business (2018-2024)
11.2.5 Gilead Sciences Recent Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Drugs Based on CAR T-cell Introduction
11.3.4 Bristol-Myers Squibb Revenue in Drugs Based on CAR T-cell Business (2018-2024)
11.3.5 Bristol-Myers Squibb Recent Developments
11.4 J & J
11.4.1 J & J Company Details
11.4.2 J & J Business Overview
11.4.3 J & J Drugs Based on CAR T-cell Introduction
11.4.4 J & J Revenue in Drugs Based on CAR T-cell Business (2018-2024)
11.4.5 J & J Recent Developments
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Details
11.5.2 JW Therapeutics Business Overview
11.5.3 JW Therapeutics Drugs Based on CAR T-cell Introduction
11.5.4 JW Therapeutics Revenue in Drugs Based on CAR T-cell Business (2018-2024)
11.5.5 JW Therapeutics Recent Developments
11.6 FOSUNKite
11.6.1 FOSUNKite Company Details
11.6.2 FOSUNKite Business Overview
11.6.3 FOSUNKite Drugs Based on CAR T-cell Introduction
11.6.4 FOSUNKite Revenue in Drugs Based on CAR T-cell Business (2018-2024)
11.6.5 FOSUNKite Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Drugs Based on CAR T-cell Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of CD19-targeted
Table 3. Key Players of BCMA-targeted
Table 4. Global Drugs Based on CAR T-cell Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Drugs Based on CAR T-cell Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Drugs Based on CAR T-cell Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Drugs Based on CAR T-cell Market Share by Region (2018-2024)
Table 8. Global Drugs Based on CAR T-cell Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Drugs Based on CAR T-cell Market Share by Region (2024-2029)
Table 10. Drugs Based on CAR T-cell Market Trends
Table 11. Drugs Based on CAR T-cell Market Drivers
Table 12. Drugs Based on CAR T-cell Market Challenges
Table 13. Drugs Based on CAR T-cell Market Restraints
Table 14. Global Drugs Based on CAR T-cell Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Drugs Based on CAR T-cell Revenue Share by Players (2018-2024)
Table 16. Global Top Drugs Based on CAR T-cell by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs Based on CAR T-cell as of 2022)
Table 17. Global Drugs Based on CAR T-cell Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Drugs Based on CAR T-cell Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Drugs Based on CAR T-cell, Headquarters and Area Served
Table 20. Global Key Players of Drugs Based on CAR T-cell, Product and Application
Table 21. Global Key Players of Drugs Based on CAR T-cell, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drugs Based on CAR T-cell Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Drugs Based on CAR T-cell Revenue Market Share by Type (2018-2024)
Table 25. Global Drugs Based on CAR T-cell Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Drugs Based on CAR T-cell Revenue Market Share by Type (2024-2029)
Table 27. Global Drugs Based on CAR T-cell Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Drugs Based on CAR T-cell Revenue Share by Application (2018-2024)
Table 29. Global Drugs Based on CAR T-cell Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Drugs Based on CAR T-cell Revenue Share by Application (2024-2029)
Table 31. North America Drugs Based on CAR T-cell Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Drugs Based on CAR T-cell Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Drugs Based on CAR T-cell Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Drugs Based on CAR T-cell Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Drugs Based on CAR T-cell Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Drugs Based on CAR T-cell Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Drugs Based on CAR T-cell Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Drugs Based on CAR T-cell Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Drugs Based on CAR T-cell Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Drugs Based on CAR T-cell Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Drugs Based on CAR T-cell Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Drugs Based on CAR T-cell Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Drugs Based on CAR T-cell Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Drugs Based on CAR T-cell Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Drugs Based on CAR T-cell Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Drugs Based on CAR T-cell Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Drugs Based on CAR T-cell Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Drugs Based on CAR T-cell Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Drugs Based on CAR T-cell Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Drugs Based on CAR T-cell Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Drugs Based on CAR T-cell Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Drugs Based on CAR T-cell Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Drugs Based on CAR T-cell Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Drugs Based on CAR T-cell Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Drugs Based on CAR T-cell Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Drugs Based on CAR T-cell Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Drugs Based on CAR T-cell Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Drugs Based on CAR T-cell Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Drugs Based on CAR T-cell Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Drugs Based on CAR T-cell Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Drugs Based on CAR T-cell Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Drugs Based on CAR T-cell Market Size by Country (2024-2029) & (US$ Million)
Table 63. Novartis Company Details
Table 64. Novartis Business Overview
Table 65. Novartis Drugs Based on CAR T-cell Product
Table 66. Novartis Revenue in Drugs Based on CAR T-cell Business (2018-2024) & (US$ Million)
Table 67. Novartis Recent Developments
Table 68. Gilead Sciences Company Details
Table 69. Gilead Sciences Business Overview
Table 70. Gilead Sciences Drugs Based on CAR T-cell Product
Table 71. Gilead Sciences Revenue in Drugs Based on CAR T-cell Business (2018-2024) & (US$ Million)
Table 72. Gilead Sciences Recent Developments
Table 73. Bristol-Myers Squibb Company Details
Table 74. Bristol-Myers Squibb Business Overview
Table 75. Bristol-Myers Squibb Drugs Based on CAR T-cell Product
Table 76. Bristol-Myers Squibb Revenue in Drugs Based on CAR T-cell Business (2018-2024) & (US$ Million)
Table 77. Bristol-Myers Squibb Recent Developments
Table 78. J & J Company Details
Table 79. J & J Business Overview
Table 80. J & J Drugs Based on CAR T-cell Product
Table 81. J & J Revenue in Drugs Based on CAR T-cell Business (2018-2024) & (US$ Million)
Table 82. J & J Recent Developments
Table 83. JW Therapeutics Company Details
Table 84. JW Therapeutics Business Overview
Table 85. JW Therapeutics Drugs Based on CAR T-cell Product
Table 86. JW Therapeutics Revenue in Drugs Based on CAR T-cell Business (2018-2024) & (US$ Million)
Table 87. JW Therapeutics Recent Developments
Table 88. FOSUNKite Company Details
Table 89. FOSUNKite Business Overview
Table 90. FOSUNKite Drugs Based on CAR T-cell Product
Table 91. FOSUNKite Revenue in Drugs Based on CAR T-cell Business (2018-2024) & (US$ Million)
Table 92. FOSUNKite Recent Developments
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drugs Based on CAR T-cell Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Drugs Based on CAR T-cell Market Share by Type: 2022 VS 2029
Figure 3. CD19-targeted Features
Figure 4. BCMA-targeted Features
Figure 5. Global Drugs Based on CAR T-cell Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Drugs Based on CAR T-cell Market Share by Application: 2022 VS 2029
Figure 7. Lymphoma Case Studies
Figure 8. Multiple Myeloma Case Studies
Figure 9. Drugs Based on CAR T-cell Report Years Considered
Figure 10. Global Drugs Based on CAR T-cell Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Drugs Based on CAR T-cell Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Drugs Based on CAR T-cell Market Share by Region: 2022 VS 2029
Figure 13. Global Drugs Based on CAR T-cell Market Share by Players in 2022
Figure 14. Global Top Drugs Based on CAR T-cell Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs Based on CAR T-cell as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Drugs Based on CAR T-cell Revenue in 2022
Figure 16. North America Drugs Based on CAR T-cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Drugs Based on CAR T-cell Market Share by Type (2018-2029)
Figure 18. North America Drugs Based on CAR T-cell Market Share by Application (2018-2029)
Figure 19. North America Drugs Based on CAR T-cell Market Share by Country (2018-2029)
Figure 20. United States Drugs Based on CAR T-cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Drugs Based on CAR T-cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Drugs Based on CAR T-cell Market Size YoY (2018-2029) & (US$ Million)
Figure 23. Europe Drugs Based on CAR T-cell Market Share by Type (2018-2029)
Figure 24. Europe Drugs Based on CAR T-cell Market Share by Application (2018-2029)
Figure 25. Europe Drugs Based on CAR T-cell Market Share by Country (2018-2029)
Figure 26. Germany Drugs Based on CAR T-cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Drugs Based on CAR T-cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Drugs Based on CAR T-cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Drugs Based on CAR T-cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Drugs Based on CAR T-cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Drugs Based on CAR T-cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. China Drugs Based on CAR T-cell Market Size YoY (2018-2029) & (US$ Million)
Figure 33. China Drugs Based on CAR T-cell Market Share by Type (2018-2029)
Figure 34. China Drugs Based on CAR T-cell Market Share by Application (2018-2029)
Figure 35. Asia Drugs Based on CAR T-cell Market Size YoY (2018-2029) & (US$ Million)
Figure 36. Asia Drugs Based on CAR T-cell Market Share by Type (2018-2029)
Figure 37. Asia Drugs Based on CAR T-cell Market Share by Application (2018-2029)
Figure 38. Asia Drugs Based on CAR T-cell Market Share by Region (2018-2029)
Figure 39. Japan Drugs Based on CAR T-cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. South Korea Drugs Based on CAR T-cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. China Taiwan Drugs Based on CAR T-cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Southeast Asia Drugs Based on CAR T-cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. India Drugs Based on CAR T-cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Australia Drugs Based on CAR T-cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East, Africa, and Latin America Drugs Based on CAR T-cell Market Size YoY (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Drugs Based on CAR T-cell Market Share by Type (2018-2029)
Figure 47. Middle East, Africa, and Latin America Drugs Based on CAR T-cell Market Share by Application (2018-2029)
Figure 48. Middle East, Africa, and Latin America Drugs Based on CAR T-cell Market Share by Country (2018-2029)
Figure 49. Brazil Drugs Based on CAR T-cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Mexico Drugs Based on CAR T-cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Turkey Drugs Based on CAR T-cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Drugs Based on CAR T-cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Israel Drugs Based on CAR T-cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. GCC Countries Drugs Based on CAR T-cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Novartis Revenue Growth Rate in Drugs Based on CAR T-cell Business (2018-2024)
Figure 56. Gilead Sciences Revenue Growth Rate in Drugs Based on CAR T-cell Business (2018-2024)
Figure 57. Bristol-Myers Squibb Revenue Growth Rate in Drugs Based on CAR T-cell Business (2018-2024)
Figure 58. J & J Revenue Growth Rate in Drugs Based on CAR T-cell Business (2018-2024)
Figure 59. JW Therapeutics Revenue Growth Rate in Drugs Based on CAR T-cell Business (2018-2024)
Figure 60. FOSUNKite Revenue Growth Rate in Drugs Based on CAR T-cell Business (2018-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries